Valuation Eli Lilly and Company

Equities

Market Closed - Nyse Other stock markets 21:00:02 13/02/2026 GMT			5-day change	1st Jan Change
1,040.00 ^USD	+0.33%		-1.72%	-3.23%

02-13	Soros Fund Management cuts share stake in Alphabet, raises share stake in Apple, Uber	RE
02-13	US could take action including fines against Hims after brief Wegovy copy launch	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	250,419	347,613	524,224	695,134	962,248	929,092	-	-
Change	-	38.81%	50.81%	32.6%	38.43%	-3.45%	-	-
Enterprise Value (EV) ¹	263,395	361,640	546,522	725,355	962,248	945,449	922,917	902,992
Change	-	37.3%	51.12%	32.72%	32.66%	-1.75%	-2.38%	-2.16%
P/E ratio	45.1x	53x	101x	65.9x	46.8x	31.1x	26x	21.4x
PBR	29.4x	32.7x	48.9x	49x	-	19x	12.8x	9.19x
PEG	-	4.2x	-6.3x	1x	0.5x	0.7x	1.3x	1x
Capitalization / Revenue	8.84x	12.2x	15.4x	15.4x	14.8x	11.6x	9.91x	8.71x
EV / Revenue	9.3x	12.7x	16x	16.1x	14.8x	11.8x	9.84x	8.46x
EV / EBITDA	26.3x	38.2x	63.7x	45.1x	-	23.7x	19.3x	16.2x
EV / EBIT	31.1x	45.5x	77.4x	50.7x	35.3x	24.8x	20.5x	17.1x
EV / FCF	44.3x	69.1x	690x	193x	-	54.9x	34.5x	26.7x
FCF Yield	2.26%	1.45%	0.15%	0.52%	-	1.82%	2.9%	3.74%
Dividend per Share ²	3.4	3.92	4.52	5.2	6	6.595	7.37	8.544
Rate of return	1.23%	1.07%	0.78%	0.67%	0.56%	0.63%	0.71%	0.82%
EPS ²	6.12	6.9	5.8	11.71	22.95	33.41	40.01	48.56
Distribution rate	55.6%	56.8%	77.9%	44.4%	26.1%	19.7%	18.4%	17.6%
Net sales ¹	28,318	28,541	34,124	45,043	65,179	80,175	93,755	106,730
EBITDA ¹	10,005	9,472	8,584	16,079	-	39,894	47,729	55,834
EBIT ¹	8,457	7,950	7,057	14,313	27,274	38,065	45,043	52,699
Net income ¹	5,582	6,245	5,240	10,590	20,640	30,413	36,107	43,147
Net Debt ¹	12,976	14,027	22,298	30,221	-	16,357	-6,175	-26,100
Reference price ²	276.22	365.84	582.92	772.00	1,074.68	1,040.00	1,040.00	1,040.00
Nbr of stocks (in thousands)	906,592	950,178	899,307	900,432	895,381	893,357	-	-
Announcement Date	03/02/22	02/02/23	06/02/24	06/02/25	04/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	31.13x	11.79x	23.7x	0.63%	929B
JOHNSON & JOHNSON	22.11x	6.52x	18.11x	2.12%	587B
ABBVIE INC.	64.64x	7.64x	18.92x	2.82%	409B
ROCHE HOLDING AG	18.87x	4.7x	11.65x	2.79%	374B
ASTRAZENECA PLC	32.49x	5.82x	17.36x	1.58%	320B
NOVARTIS AG	21.47x	6x	14.69x	2.7%	311B
MERCK & CO., INC.	15.68x	5.03x	10.97x	2.66%	301B
NOVO NORDISK A/S	14.81x	5.11x	10.76x	3.49%	219B
AMGEN INC.	28.69x	6.7x	11.46x	2.59%	199B
GILEAD SCIENCES, INC.	22.73x	7.03x	12.85x	2.14%	192B
Average	27.26x	6.63x	15.05x	2.35%	384.09B
Weighted average by Cap.	28.77x	7.47x	16.99x	2.05%